WEKO3
アイテム
{"_buckets": {"deposit": "35d55000-a6fd-4f21-b1f8-195faa93e8a5"}, "_deposit": {"created_by": 1, "id": "44086", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "44086"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00044086", "sets": ["1"]}, "author_link": ["438260", "438267", "438259", "438268", "438270", "438266", "438265", "438261", "438262", "438269", "438263", "438264"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1999", "bibliographicIssueDateType": "Issued"}, "bibliographicPageEnd": "119", "bibliographicPageStart": "115", "bibliographicVolumeNumber": "38", "bibliographic_titles": [{"bibliographic_title": "Nuklearmedizin"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Aim: The purpose of this study was to assess the potential for radioimmunodetection (RAID) of murine anti-carcinoembryonic antigen (CEA) monoclonal antibody (MAb) F33-104 laveled with technetium-99m(99m-Tc) by a reduction-mediated labeling method. Methods: The binding capacity of 99m-Tc-labeled anti-CEA MAb F33-104 with CEA by means of in vitro procedures such as immunoradiometric assay and cell binding assay and the biodistribution of 99m-Tc-labeled anti-CEA MAb F33-104 in normal nude mice and nude mice bearing human colon adenocarcinoma LS180 tumor were investigated and compared with 99m-Tc-labeled anti-CEA MAb BW431/26. Results: The in vitro binding rate of 99m-Tc-labeled anti-CEA MAb F33-104 with CEA in solution and attached to the cell membrane was significantly higher than 99m-Tc-labeled anti-CEA MAb BW431/261 (31.4 0.95% vs. 11.9 0.55% at 100 ng/mL of solube CEA, 83.5 2.84% vs, 54.0 2.54% at 107 of LS 180 cells). In vivo, accumulation of 99m-Tc-labeled anti-CEA MAbF33-104 was higher at 18 h postinjection than 99m-Tc-labeled anti-CEA MAb BW431/26(20.1 3.50% ID/g vs. 14.4 3.30% ID/g). 99m-Tc-activity in the kidneys of nude mice bearing tumor was higher at 18 h postinjection than at 3 h (12.8 2.10% ID/g vs, 8.01 2.40% ID/g of 99m-Tc-labeled anti-CEA MAb F33-104, 10.7 1.70% ID/g vs. 8.10 1.75% ID/g of 99m-Tc-labeled anti-CEA MAb BW431/26). Conclusion: 99m-Tc-labeled anti-CEA MAb F33-104 is a potential novel agent for RAID of recurrent colorectal cancer.", "subitem_description_type": "Abstract"}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0029-5566", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Watanabe, Naoyuki"}], "nameIdentifiers": [{"nameIdentifier": "438259", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Oriuchi, Noboru"}], "nameIdentifiers": [{"nameIdentifier": "438260", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tanada, Shuji"}], "nameIdentifiers": [{"nameIdentifier": "438261", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Murata, Hajime"}], "nameIdentifiers": [{"nameIdentifier": "438262", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Inoue, Tomio"}], "nameIdentifiers": [{"nameIdentifier": "438263", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sasaki, Yasuhito"}], "nameIdentifiers": [{"nameIdentifier": "438264", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "et.al"}], "nameIdentifiers": [{"nameIdentifier": "438265", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "渡辺 直行", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "438266", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "棚田 修二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "438267", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "村田 啓", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "438268", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "井上 登美夫", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "438269", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "佐々木 康人", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "438270", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "In Vitro and in Vivo Comparison of Binding of 99m-Tc-labeled Anti-CEA MAb F33-104 with 99m-Tc-labeled Anti-CEA MAb BW431/26", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "In Vitro and in Vivo Comparison of Binding of 99m-Tc-labeled Anti-CEA MAb F33-104 with 99m-Tc-labeled Anti-CEA MAb BW431/26"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/44086", "pubdate": {"attribute_name": "公開日", "attribute_value": "2006-05-22"}, "publish_date": "2006-05-22", "publish_status": "0", "recid": "44086", "relation": {}, "relation_version_is_last": true, "title": ["In Vitro and in Vivo Comparison of Binding of 99m-Tc-labeled Anti-CEA MAb F33-104 with 99m-Tc-labeled Anti-CEA MAb BW431/26"], "weko_shared_id": -1}
In Vitro and in Vivo Comparison of Binding of 99m-Tc-labeled Anti-CEA MAb F33-104 with 99m-Tc-labeled Anti-CEA MAb BW431/26
https://repo.qst.go.jp/records/44086
https://repo.qst.go.jp/records/44086c3ae09df-2fcf-4ca1-9e5d-f47e39e58a4f
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2006-05-22 | |||||
タイトル | ||||||
タイトル | In Vitro and in Vivo Comparison of Binding of 99m-Tc-labeled Anti-CEA MAb F33-104 with 99m-Tc-labeled Anti-CEA MAb BW431/26 | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Watanabe, Naoyuki
× Watanabe, Naoyuki× Oriuchi, Noboru× Tanada, Shuji× Murata, Hajime× Inoue, Tomio× Sasaki, Yasuhito× et.al× 渡辺 直行× 棚田 修二× 村田 啓× 井上 登美夫× 佐々木 康人 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Aim: The purpose of this study was to assess the potential for radioimmunodetection (RAID) of murine anti-carcinoembryonic antigen (CEA) monoclonal antibody (MAb) F33-104 laveled with technetium-99m(99m-Tc) by a reduction-mediated labeling method. Methods: The binding capacity of 99m-Tc-labeled anti-CEA MAb F33-104 with CEA by means of in vitro procedures such as immunoradiometric assay and cell binding assay and the biodistribution of 99m-Tc-labeled anti-CEA MAb F33-104 in normal nude mice and nude mice bearing human colon adenocarcinoma LS180 tumor were investigated and compared with 99m-Tc-labeled anti-CEA MAb BW431/26. Results: The in vitro binding rate of 99m-Tc-labeled anti-CEA MAb F33-104 with CEA in solution and attached to the cell membrane was significantly higher than 99m-Tc-labeled anti-CEA MAb BW431/261 (31.4 0.95% vs. 11.9 0.55% at 100 ng/mL of solube CEA, 83.5 2.84% vs, 54.0 2.54% at 107 of LS 180 cells). In vivo, accumulation of 99m-Tc-labeled anti-CEA MAbF33-104 was higher at 18 h postinjection than 99m-Tc-labeled anti-CEA MAb BW431/26(20.1 3.50% ID/g vs. 14.4 3.30% ID/g). 99m-Tc-activity in the kidneys of nude mice bearing tumor was higher at 18 h postinjection than at 3 h (12.8 2.10% ID/g vs, 8.01 2.40% ID/g of 99m-Tc-labeled anti-CEA MAb F33-104, 10.7 1.70% ID/g vs. 8.10 1.75% ID/g of 99m-Tc-labeled anti-CEA MAb BW431/26). Conclusion: 99m-Tc-labeled anti-CEA MAb F33-104 is a potential novel agent for RAID of recurrent colorectal cancer. | |||||
書誌情報 |
Nuklearmedizin 巻 38, p. 115-119, 発行日 1999 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0029-5566 |